gdc
Cancer ResearchClinical TrialsImmunotherapyPediatric Cancer

Is CAR T-Cell Therapy Safe and Effective?

Claire White discusses the role of the FDA in evaluating new and promising treatments such as CAR T-cell therapy and the complexity of getting approvals.
Video Library – March 6, 2019
Claire White, BSN, RN, CPHON
The Children's Hospital of Philadelphia, Philadelphia, PA
Claire White discusses the role of the FDA in evaluating new and promising treatments such as CAR T-cell therapy and the complexity of getting approvals.
Recommended For You
Breast CancerFDA Approvals, News & UpdatesImmunotherapy
First Immunotherapy Approved for Patients with Advanced or Metastatic Triple-Negative Breast Cancer Expressing PD-L1
In March 2019, the FDA approved Tecentriq (atezolizumab), a PD-L1 inhibitor, in combination with Abraxane (paclitaxel protein-bound), for use in adults with locally advanced or metastatic triple-negative breast cancer whose tumors cannot be removed by surgery and express PD-L1, as identified by an FDA-approved test. This is the first FDA-approved immunotherapy for patients with advanced or metastatic triple-negative breast cancer.
Cancer ResearchSurvivorship
The Link between Obesity and Cancer
By Kelsey Moroz
Obesity is associated with about 40% of cancers in the United States. This link is strongest in several types of cancer, including kidney, gastric, pancreatic, endometrial, and esophageal cancer. Significant weight reduction may help to reduce the risk for cancer.
Clinical TrialsPatient StoriesSkin Cancer
The Gift of Life After Skin Cancer: From Surgeon to Being a Patient
By David Crouch, MD
After a lifetime of treating patients, Dr. David Crouch understood his own illness left little room for optimism as skin cancer returned again and again. As a last resort, he joined a clinical trial of a new immunotherapy that provided him a new lease on life. Today, after 2 years in remission, his mission is to educate people about this cancer and this immunotherapy.
Last modified: March 6, 2019

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country